CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Aviv Weinstein

OPENALEX: A5089715618↗ORCID: 0000-0002-9465-9943↗

Affiliations

Organizations

Ariel Universityauthorship · IL Hadassah Medical Centerauthorship · IL Psychiatric Medical Centerauthorship · AM Tel Aviv Sourasky Medical Centerauthorship · IL

Public evidence

7 connected articles

A brain imaging study of dopamine receptor D2 availability in cannabis dependent users after recovery from cannabis-induced psychosis2023 · PubMed Central Open Access Editorial: Psychological Aspects of Cannabis Use and Cannabis Use Disorder.2021 · PubMed Central Open Access Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users.2020 · Europe PMC Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility.2020 · Europe PMC The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review.2018 · Europe PMC Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.2018 · Europe PMC Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.2017 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Aviv Weinstein - Medical Cannabis Research Engine